Drugs / Piper crocatum
last change Apr 2023 re-read 9 days ago

Piper crocatum

Developed for
anogenital human papillomavirus infection
Investigated by
Hasanuddin University

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05622916 Nov 2022 → Feb 2023 anogenital human papillomavirus infection Hasanuddin University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Piper crocatum ClinicalTrials.gov intervention name — accepted as the source's own label NCT05622916 ↗
Route Topical “Daily topical application (twice/day, in the morning and 30-60 minutes before bed at night) for 56 days.” NCT05622916 ↗